Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Drummond

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Neurosciences|October 8, 2023
Immune-related neurodegeneration in the midbrain causes pulmonary dysfunction in murine cryptococcal IRISRachael Dangarembizi, Rebecca Drummond
Preventing Chronic Disease|January 27, 2005
Developing and adapting a family-based diabetes program at the U.S.-Mexico borderNicolette I Teufel-Shone, Rebecca Drummond, Ulrike Rawiel
Pediatric Neurology|August 7, 2015
Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut SyndromeJuliann M Paolicchi, Gail Ross, Deborah Lee, et al.
Epilepsy & Behavior : E&B|October 6, 2014
Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experienceJames W Wheless, Jouko Isojarvi, Deborah Lee, et al.
Epilepsia|May 19, 2015
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsyDwain Tolbert, James Cloyd, Victor Biton, et al.
Plos One|April 13, 2012
Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cellsStefano Caserta, Norman Nausch, Amy Sawtell, et al.
Epilepsy & Behavior : E&B|May 6, 2015
Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term clinical trial resultsYu-Tze Ng, Joan Conry, Wendy G Mitchell, et al.
Epilepsy & Behavior : E&B|November 13, 2012
Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension studyYu-Tze Ng, Joan Conry, Juliann Paolicchi, et al.
Phytotherapy Research : PTR|March 25, 2006
Use of herbal remedies by diabetic Hispanic women in the southwestern United StatesLane Johnson, Hal Strich, Ann Taylor, et al.
Epilepsia|March 4, 2014
Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 yearsJoan A Conry, Yu-Tze Ng, Lydia Kernitsky, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Neurosciences|October 8, 2023
Immune-related neurodegeneration in the midbrain causes pulmonary dysfunction in murine cryptococcal IRISRachael Dangarembizi, Rebecca Drummond
Preventing Chronic Disease|January 27, 2005
Developing and adapting a family-based diabetes program at the U.S.-Mexico borderNicolette I Teufel-Shone, Rebecca Drummond, Ulrike Rawiel
Pediatric Neurology|August 7, 2015
Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut SyndromeJuliann M Paolicchi, Gail Ross, Deborah Lee, et al.
Epilepsy & Behavior : E&B|October 6, 2014
Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experienceJames W Wheless, Jouko Isojarvi, Deborah Lee, et al.
Epilepsia|May 19, 2015
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsyDwain Tolbert, James Cloyd, Victor Biton, et al.
Plos One|April 13, 2012
Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cellsStefano Caserta, Norman Nausch, Amy Sawtell, et al.
Epilepsy & Behavior : E&B|May 6, 2015
Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term clinical trial resultsYu-Tze Ng, Joan Conry, Wendy G Mitchell, et al.
Epilepsy & Behavior : E&B|November 13, 2012
Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension studyYu-Tze Ng, Joan Conry, Juliann Paolicchi, et al.
Phytotherapy Research : PTR|March 25, 2006
Use of herbal remedies by diabetic Hispanic women in the southwestern United StatesLane Johnson, Hal Strich, Ann Taylor, et al.
Epilepsia|March 4, 2014
Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 yearsJoan A Conry, Yu-Tze Ng, Lydia Kernitsky, et al.
Pageof 1